Trademarkia Logo

Canada

C$
Trademark Search in Canada
RELYVRIO

View On IC.GC.CA

RELYVRIO
REGISTERED

on 24 Nov 2023

Last Applicant/ Owned by

Amylyx Pharmaceuticals, Inc.

43 Thorndike StreetCambridge MA 02141

US

Serial Number

2104993 filed on 19th Mar 2021

Registration Number

TMA1210714 registered on 24th Nov 2023

Registration expiry Date

19th Mar 2031

Correspondent Address

SMART & BIGGAR LP

Scotia Plaza, 40 King Street West40th FloorToronto

ONTARIO

CA

M5H3Y2

RELYVRIO

Trademark usage description

pharmaceutical preparations for the treatment of neurological diseases and neurodegenerative diseases, namely, therapeutics that target neuronal degen Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of neurological diseases and neurodegenerative diseases, namely, therapeutics that target neuronal degeneration pathways to reduce neuronal death and dysfunction

Classification kind code

11

Mark Details

Serial Number

2104993

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 19th Aug 2022		Search Recorded
Submitted for opposition 20
on 19th Aug 2022		Examiner's First Report
Submitted for opposition 223
on 19th Aug 2022		Total Provisional Refusal
Submitted for opposition 256
on 7th Mar 2022		Notification of Possible Opposition Sent
Submitted for opposition 48
on 12th Jul 2021		Agent Changed
Submitted for opposition 257
on 6th May 2021		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 5th May 2021		Created
Submitted for opposition 31
on 5th May 2021		Formalized
Submitted for opposition 228
on 19th Mar 2021		International Registration
Submitted for opposition 30
on 19th Mar 2021		Filed